Rozalina Dimitrova

Rozalina Dimitrova, a highly experienced professional in the field of neurology and clinical development, currently holds the position of Vice President in R&D Strategy for Neurotoxins at AbbVie. Prior to joining AbbVie, Rozalina served at Allergan for over 15 years, holding various leadership roles in neuroscience development. Dimitrova holds a Doctor of Medicine degree from Medical University in Sofia, Bulgaria and has a strong educational background from Emory University in Atlanta, GA.